97 related articles for article (PubMed ID: 6756859)
1. [Antibiotic sensitivity of various atypical mycobacteria in vitro].
Atef M; Ghani MA; Niazi ZM; Youssef SA; Osman K
Dtsch Tierarztl Wochenschr; 1982 Oct; 89(10):403-6. PubMed ID: 6756859
[No Abstract] [Full Text] [Related]
2. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
Sakurai N
Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
[No Abstract] [Full Text] [Related]
3. [Major antibiotic susceptibility of the clinically isolated atypical mycobacterium strains (author's transl)].
Arai T; Komatsu S; Nagatomi H
Kekkaku; 1982 Apr; 57(4):239-42. PubMed ID: 7109423
[No Abstract] [Full Text] [Related]
4. Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin.
Ortíz-Pérez A; Martín-de-Hijas N; Alonso-Rodríguez N; Molina-Manso D; Fernández-Roblas R; Esteban J
Enferm Infecc Microbiol Clin; 2011 Feb; 29(2):79-84. PubMed ID: 21333405
[TBL] [Abstract][Full Text] [Related]
5. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].
Ungheri D; Morvillo E; Sanfilippo A
G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872
[No Abstract] [Full Text] [Related]
6. Usefulness of the Etest for studying tigecycline susceptibility of non-pigmented rapidly growing mycobacteria.
Martín-de-Hijas NZ; Fernández-Roblas R; Fernandez-Martínez AI; Gadea I; Esteban J
Int J Antimicrob Agents; 2008 Oct; 32(4):366-7. PubMed ID: 18572391
[No Abstract] [Full Text] [Related]
7. [Mycobacterial bases of the therapy of mycobacterioses].
Hejný J
Z Erkr Atmungsorgane; 1982; 158(1-2):163-7. PubMed ID: 7072265
[TBL] [Abstract][Full Text] [Related]
8. [Antibacterial activity of enviomycin for atypical mycobacteria. 1. Antibacterial activity in vitro (author's transl)].
Toyohara M
Kekkaku; 1978 Apr; 53(4):255-60. PubMed ID: 661057
[No Abstract] [Full Text] [Related]
9. [In vitro and in vivo activities of cefoxitin alone or in combination with antituberculosis drugs against the Mycobacterium fortuitum complex].
Sato K; Saito H; Tomioka H
Kekkaku; 1987 Jul; 62(7):383-8. PubMed ID: 3682558
[No Abstract] [Full Text] [Related]
10. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
Toyohara M
Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
[No Abstract] [Full Text] [Related]
11. [Resistance to antitubercular drugs of atypical Mycobacterium pathogenic to man].
Casal Román M
Rev Clin Esp; 1978 Feb; 148(4):343-5. PubMed ID: 653055
[No Abstract] [Full Text] [Related]
12. [New active drugs against the tuberculosis bacillus and other mycobacteria].
de Kantor IN
Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
[No Abstract] [Full Text] [Related]
13. [Morphologic-cultural and physiologic-biochemical properties of atypical mycobacteria].
Iavors'ka HV; Sybirna RI
Mikrobiol Z; 2009; 71(4):27-34. PubMed ID: 19938613
[TBL] [Abstract][Full Text] [Related]
14. [Antimycobacterial activities of minocycline and ciprofloxacin].
Arai T; Komatsu S; Aoyagi T
Kekkaku; 1985 May; 60(5):293-7. PubMed ID: 3162057
[No Abstract] [Full Text] [Related]
15. Pulmonary Mycobacterium fortuitum infection in a dog.
Jang SS; Eckhaus MA; Saunders G
J Am Vet Med Assoc; 1984 Jan; 184(1):96-8. PubMed ID: 6698846
[No Abstract] [Full Text] [Related]
16. Comparative investigation in vitro of the sensibility of atypical mycobacteria to cycloserine and to other antibacterial substances.
Gernez-Rieux C; Devulder B
Scand J Respir Dis Suppl; 1970; 71():22-34. PubMed ID: 5271991
[No Abstract] [Full Text] [Related]
17. In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin.
Casal MJ; Rodriguez FC
Ann Microbiol (Paris); 1983; 134B(3):451-4. PubMed ID: 6675495
[TBL] [Abstract][Full Text] [Related]
18. Studies on acyclic pyrimidines as inhibitors of mycobacteria.
Srivastav NC; Manning T; Kunimoto DY; Kumar R
Bioorg Med Chem; 2007 Mar; 15(5):2045-53. PubMed ID: 17218105
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.
Cavicchioli M; Leite CQ; Sato DN; Massabni AC
Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678
[TBL] [Abstract][Full Text] [Related]
20. Clinical mycobacteriology. Drug susceptibility testing.
Heifets LB
Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
